HMC
Harvard Management Company Portfolio holdings
AUM
$1.44B
This Quarter Return
+14.54%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$1.74B
AUM Growth
+$1.74B
(-2.9%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-5.57%
Top 10 Holdings %
Top 10 Hldgs %
81.62%
Holding
43
New
5
Increased
3
Reduced
12
Closed
5
Top Buys
| 1 |
Apple
AAPL
|
$333M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
$55.1M |
| 3 |
DaVita
DVA
|
$49.2M |
| 4 |
Meta Platforms (Facebook)
META
|
$38.2M |
| 5 |
Affirm
AFRM
|
$32.2M |
Top Sells
| 1 |
Intercontinental Exchange
ICE
|
$163M |
| 2 |
Adobe
ADBE
|
$155M |
| 3 |
Royalty Pharma
RPRX
|
$146M |
| 4 |
Microsoft
MSFT
|
$61.7M |
| 5 |
Palo Alto Networks
PANW
|
$35.2M |
Sector Composition
| 1 | Healthcare | 38.04% |
| 2 | Technology | 27.47% |
| 3 | Consumer Discretionary | 12.12% |
| 4 | Communication Services | 10.39% |
| 5 | Financials | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares Core S&P Small-Cap ETF
IJR
$84.2B
| $5.7M | 0.33% |
50,474
+170
| +0.3% | +$19.2K |
|
27
Fulcrum Therapeutics
FULC
$347M
| $4.3M | 0.25% |
410,714
| – | – |
|
28
Vanguard FTSE Emerging Markets ETF
VWO
$96.3B
| $4.01M | 0.23% |
73,804
-6,697
| -8% | -$364K |
|
|
PRDS
29
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $4M | 0.23% |
400,000
| – | – |
|
30
iShares Core S&P Mid-Cap ETF
IJH
$99.1B
| $3.41M | 0.2% |
12,683
-3,446
| -21% | -$926K |
|
31
Dianthus Therapeutics
DNTH
$779M
| $3.25M | 0.19% |
332,610
| – | – |
|
32
Pinduoduo
PDD
$176B
| $3.24M | 0.19% |
25,493
-16,997
| -40% | -$2.16M |
|
33
Seres Therapeutics
MCRB
$164M
| $3.15M | 0.18% |
131,847
| – | – |
|
|
DBTX
34
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $2.83M | 0.16% |
328,798
| – | – |
|
35
Dyne Therapeutics
DYN
$1.9B
| $2.26M | 0.13% |
107,252
| – | – |
|
36
Disc Medicine
IRON
$2.14B
| $1.62M | 0.09% |
250,000
| – | – |
|
|
NCNA
37
NuCana
NCNA
$5.71M
| $1.07M | 0.06% |
387,124
-605,281
| -61% | -$1.68M |
|
38
Quince Therapeutics
QNCX
$85.9M
| $156K | 0.01% |
+2,937
| New | +$156K |
|
|
39
Adobe
ADBE
$147B
| – | – |
-326,100
| Closed | -$155M |
|
40
Salesforce
CRM
$244B
| – | – |
-164,622
| Closed | -$34.9M |
|
|
DADA
41
DELISTED
Dada Nexus
DADA
| – | – |
-49,887
| Closed | -$1.35M |
|
|
42
Microsoft
MSFT
$3.74T
| – | – |
-261,792
| Closed | -$61.7M |
|
43
Roblox
RBLX
$92.3B
| – | – |
-197,642
| Closed | -$12.8M |
|